Literature DB >> 11848132

Study of interleukin-10 and interleukin-12 productions in response to lipopolysaccharides extracted from two different Brucella strains.

Amina Kariminia1, Gholamreza Kavoossy, Shohreh Khatami, Esmaeil Zowghi, Sussan K Ardestani.   

Abstract

The aim of the present study is to investigate the cytokines induction by smooth lipopolysaccharides (S-LPS) extracted from Brucella melitensis (Rev1 vaccine strain) and Brucella abortus (a field isolate). These lipopolysaccharides were used to induce inflammatory cytokines production in peripheral blood cell culture of healthy individuals. Secretion of IL-10 and IL-12 (p70) were measured by means of specific Elisa. In addition, intracellular expression of IL-12 was assessed in CD14+ cells by flow cytometry. It was shown that Brucella LPS is a potent inducer of IL-10. However interferon gamma (IFN-gamma) priming was able to significantly decrease the production of IL-10. Flow cytometry studies showed that LPS alone was not able to induce intracellular IL-12 expression in CD14+ cells. Nevertheless, IFN-gamma priming significantly increased the percentage of CD14+ IL-12+ cells. In conclusion, it was demonstrated that the Brucella LPS could be a potent inducer of IL-10 and induction of IL-12 production needs the most favorable conditions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11848132     DOI: 10.1016/s0147-9571(01)00029-7

Source DB:  PubMed          Journal:  Comp Immunol Microbiol Infect Dis        ISSN: 0147-9571            Impact factor:   2.268


  6 in total

1.  Influence of Brucella abortus lipopolysaccharide as an adjuvant on the immunogenicity of HPV-16 L1VLP vaccine in mice.

Authors:  Zahra Kianmehr; Hoorieh Soleimanjahi; Susan Kaboudanian Ardestani; Fatemeh Fotouhi; Asghar Abdoli
Journal:  Med Microbiol Immunol       Date:  2014-09-04       Impact factor: 3.402

2.  Qualitatively distinct patterns of cytokines are released by human dendritic cells in response to different pathogens.

Authors:  Karen Scott; Maria Manunta; Conrad Germain; Peter Smith; Meleri Jones; Peter Mitchell; Daniele Dessi; Kathleen Branigan Bamford; Robert I Lechler; Pier Luigi Fiori; Graham R Foster; Giovanna Lombardi
Journal:  Immunology       Date:  2005-10       Impact factor: 7.397

3.  CD80/CD28 co-stimulation in human brucellosis.

Authors:  P Skendros; P Boura; F Kamaria; M Raptopoulou-Gigi
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

4.  Comparison of Biological and Immunological Characterization of Lipopolysaccharides From Brucella abortus RB51 and S19.

Authors:  Zahra Kianmehr; Sussan Kaboudanian Ardestani; Hoorieh Soleimanjahi; Fatemeh Fotouhi; Saeed Alamian; Shahin Ahmadian
Journal:  Jundishapur J Microbiol       Date:  2015-11-07       Impact factor: 0.747

5.  Brucella Omp25 Upregulates miR-155, miR-21-5p, and miR-23b to Inhibit Interleukin-12 Production via Modulation of Programmed Death-1 Signaling in Human Monocyte/Macrophages.

Authors:  Beibei Cui; Wenli Liu; Xiaoya Wang; Yu Chen; Qian Du; Xiaomin Zhao; Hai Zhang; Shan-Lu Liu; Dewen Tong; Yong Huang
Journal:  Front Immunol       Date:  2017-06-26       Impact factor: 7.561

6.  Chronic brucellosis patients retain low frequency of CD4+ T-lymphocytes expressing CD25 and CD28 after Escherichia coli LPS stimulation of PHA-cultured PBMCs.

Authors:  Panagiotis Skendros; Alexandros Sarantopoulos; Konstantinos Tselios; Panagiota Boura
Journal:  Clin Dev Immunol       Date:  2009-01-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.